Browsing Tag
Fibroids
Inaugural Fibroids Awareness Day aims to break the silence and isolation around misunderstood…
MONTREAL, July 21, 2022 (GLOBE NEWSWIRE) -- Today, Vivre 100 Fibromes (Living Without Fibroids) officially declared…
Read More...
Read More...
ObsEva Announces UK MHRA Marketing Authorization for Yselty® (linzagolix), an Oral GnRH Antagonist,…
-Yselty® (linzagolix) is the first and only approved GnRH antagonist to provide flexible dosing options with and…
Read More...
Read More...
ObsEva Announces European Commission Marketing Authorization for Yselty® (linzagolix), an Oral GnRH…
-Yselty® (linzagolix) is the first and only approved GnRH antagonist to provide flexible dosing options with and…
Read More...
Read More...
ObsEva Announces European Commission Marketing Authorization for Yselty® (linzagolix), an Oral GnRH…
-Yselty® (linzagolix) is the first and only approved GnRH antagonist to provide flexible dosing options with and…
Read More...
Read More...
ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix for the Treatment of Uterine…
-Additional data from the PRIMROSE Phase 3 studies of linzagolix featured in four posters. Oral presentation took…
Read More...
Read More...
ObsEva Announces Confirmation of Positive CHMP Opinion for Linzagolix, an Oral GnRH Antagonist, for…
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – April 25, 2022 – ObsEva…
Read More...
Read More...
Freedom from fibroids
By Express News Service
A woman should feel empowered to do what she wishes to accomplish in her…
Read More...
Read More...
ObsEva Provides Update on EU Marketing Authorisation Process for Linzagolix, an Oral GnRH…
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – February 4, 2022 –…
Read More...
Read More...
Rapper and Actor Eve’s Uterine Fibroids
Rapper, former "The Talk"…
Read More...
Read More...